During the past decade, Universitäts- und Rehabilitationskliniken Ulm (RKU) - Neurologische Universitätsklinik conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitäts- und Rehabilitationskliniken Ulm (RKU) - Neurologische Universitätsklinik" #1 collaborator was "European Commission" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Universitäts- und Rehabilitationskliniken Ulm (RKU) - Neurologische Universitätsklinik" are "Amyotrophic Lateral Sclerosis" (2 trials). Many other conditions were trialed in "Universitäts- und Rehabilitationskliniken Ulm (RKU) - Neurologische Universitätsklinik" in a lesser frequency.

Most popular intervention types in "Universitäts- und Rehabilitationskliniken Ulm (RKU) - Neurologische Universitätsklinik" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Olesoxime" (1 trials), "Placebo Comparator" (1 trials), "Riluzole" (1 trials) and "TRO19622" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitäts- und Rehabilitationskliniken Ulm (RKU) - Neurologische Universitätsklinik" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Universitäts- und Rehabilitationskliniken Ulm (RKU) - Neurologische Universitätsklinik". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Universitäts- und Rehabilitationskliniken Ulm (RKU) - Neurologische Universitätsklinik, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitäts- und Rehabilitationskliniken Ulm (RKU) - Neurologische Universitätsklinik, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".